Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/1993
10/05/1993US5250295 Natural killer cell enhancing factor
10/05/1993US5250294 Improved perfusion medium for transplantation of organs
10/05/1993US5250293 Method for the treatment of hypersensitivity diseases by administration of anionic polymers
10/05/1993CA2093305A1 Peptides with modifications at the n terminus
10/05/1993CA1322717C Combination of renal vasodilators and alpha 1-adrenergic or ganglionic blocking agents and methods for treating diseases
10/05/1993CA1322715C Use of a tripeptide and composition thereof as an immunostimulating agent
10/05/1993CA1322714C Wound healing and bone regeneration
10/05/1993CA1322713C Compositions and methods for modulating the effect of tnf and il-1
10/03/1993CA2093165A1 Formulated medicines and processed foods to potentiate host defense activity, and methods for treatment of infectious diseases
10/03/1993CA2091313A1 Tnf-muteins
10/02/1993WO1993020105A1 Complexes of the peptidoglycan monomer (pgm) with trivalent metals, process for the manufacture thereof and their use
10/02/1993CA2133087A1 Complexes of the peptidoglycan monomer (pgm) with trivalent metals, process for the manufacture thereof and their use
10/02/1993CA2093178A1 Pharmaceutical compositions for the treatment and/or prevention of degenerative disorders in the retina
10/02/1993CA2093109A1 Morpholin- and thiomorpholin-4-ylamides
10/02/1993CA2093099A1 Recombinant human hiv-neutralizing monoclonal antibodies for prevention and treatment of hiv infection
10/01/1993WO1993020109A1 Novel antibiotic and production and use thereof
10/01/1993CA2106480A1 Antibiotics and method of producing them and use of them
09/1993
09/30/1993WO1993019373A1 Broadly reactive opsonic antibodies that react with common staphylococcal antigens
09/30/1993WO1993019203A1 Oligonucleotide modulation of protein kinase c
09/30/1993WO1993019191A1 Defective recombinant adenoviruses expressing cytokines for use in antitumoral treatment
09/30/1993WO1993019183A1 Immunization by inoculatioon of dna transcription unit
09/30/1993WO1993019180A1 Genetically engineered antibodies
09/30/1993WO1993019179A1 Ifn receptors recognition factors, protein sequences and methods of use thereof
09/30/1993WO1993019178A2 Peptides useful for inducing tolerance
09/30/1993WO1993019176A1 Leucine zippers
09/30/1993WO1993019173A1 Dna coding for aphrodisin
09/30/1993WO1993019168A1 Reconstituted cartilage tissue
09/30/1993WO1993019167A1 Methods of using antibodies against human chorionic gonadotropin-related determinants to lyse, measure and enrich malignant cells
09/30/1993WO1993019166A1 Small animal model for studying cholesterol metabolism
09/30/1993WO1993019165A1 Colon crypt cell mitogen, cell line producing it, and uses thereof
09/30/1993WO1993019163A1 Chimeric receptor genes and cells transformed therewith
09/30/1993WO1993019094A1 A monoclonal antibody to a human mdr1 multidrug resistance gene product, and uses
09/30/1993WO1993019092A1 Defective recombinant adenoviruses expressing characteristic epstein-barr virus proteins
09/30/1993WO1993019089A2 Oxygen carrier
09/30/1993WO1993019088A1 Neurotrophic peptides
09/30/1993WO1993019087A1 Chemotactic, antibiotic and lipopolysaccharide-binding peptide fragments of cap37
09/30/1993WO1993019085A1 Novel antler-derived bone growth factors
09/30/1993WO1993019084A1 Refolding and purification of insulin-like growth factor i
09/30/1993WO1993019037A1 Compounds
09/30/1993WO1993018835A1 Protein purification
09/30/1993WO1993018797A1 Method of intraoperatively detecting and locating tumoral tissues
09/30/1993WO1993018794A1 In vivo peptide therapy
09/30/1993WO1993018792A1 Selective alteration of antibody immunogenicity
09/30/1993WO1993018788A1 An antigen for diagnosis and hyposensitisation of flea allergy dermatitis in animals
09/30/1993WO1993018786A1 Use of a peptide
09/30/1993WO1993018785A1 Novel medicament
09/30/1993WO1993018784A1 Monospecific polyclonal antibodies to shiga-like toxins
09/30/1993WO1993018783A1 Use of interleukin-10 to induce the production of interleukin-1 receptor antagonist
09/30/1993WO1993018782A1 Glycosylation-mediated inhibition of factor x
09/30/1993WO1993018759A1 A dna transporter system and method of use
09/30/1993WO1993018750A1 Method for reducing side-effects of a drug
09/30/1993WO1993017040A3 Cystic fibrosis transmembrane conductance regulator (cftr) protein
09/30/1993WO1993016099A3 Dna sequences encoding novel growth/differentiation factors
09/30/1993WO1993015203A3 Polypeptides with fibronectin binding sites as modulators for matrix assembly
09/30/1993WO1993013207A3 Novel human transglutaminases
09/30/1993WO1993012814A3 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations
09/30/1993WO1992001049A3 Cd53 cell surface antigen and use thereof
09/30/1993CA2132518A1 Glycosylation-mediated inhibition of factor x
09/30/1993CA2132345A1 Oxygen carrier
09/30/1993CA2132317A1 Ifn receptors recognition factors, protein sequences and methods of use thereof
09/30/1993CA2132219A1 Novel antler-derived bone growth factors
09/30/1993CA2132095A1 Colon crypt cell mitogen, cell line producing it, and uses thereof
09/30/1993CA2132094A1 Oligonucleotide modulation of protein kinase c
09/30/1993CA2131621A1 Selective alteration of antibody immunogenicity
09/30/1993CA2131620A1 A dna transporter system and method of use
09/30/1993CA2131315A1 Method of intraoperatively detecting and locating tumoral tissues
09/30/1993CA2130173A1 Genetically engineered antibodies
09/30/1993CA2109820A1 Refolding and purification of insulin-like growth factor i
09/29/1993EP0563023A1 Use of tissue factor pathway inhibitor for the manufacture of a medicament for use in a method of inhibiting microvascular thrombosis
09/29/1993EP0562853A1 29-Demethoxyrapamycin for inducing immunosuppression
09/29/1993EP0562849A2 Steroid derivatives
09/29/1993EP0562508A2 Protein with bone formation ability and process for its production
09/29/1993EP0562132A1 Monoclonal anti-tetanus toxin antibodies and pharmaceutical compositions containing them
09/29/1993EP0562125A1 Antibody composition
09/29/1993EP0562123A1 Novel physiologically active substance epimorphine, gene which codes for same, and antibody against epimorphine
09/29/1993EP0562013A1 Human retrovirus receptor and dna coding therefor
09/29/1993EP0561971A1 Fusion polypeptides
09/29/1993EP0561965A1 Enhancement of musculature in animals
09/29/1993EP0561960A1 Leukemia inhibitory factor receptors
09/29/1993EP0561953A1 Recombinant immunotoxin composed of a single chain antibody reacting with the human transferrin receptor and diphtheria toxin
09/29/1993EP0561912A1 Lectins in probiosis
09/29/1993EP0561907A1 Proteins with changed epitopes and methods for the production thereof
09/29/1993EP0561877A1 Compounds and compositions which inhibit bone resorption
09/29/1993EP0561827A1 Tetrapeptides deriving from dalbaheptide antibiotics.
09/29/1993EP0561797A1 Transgenic model for selective targeting of gene products with a megakaryocyte promoter
09/29/1993EP0382781B1 Composition for treating cancers characterized by over-expression of the c-fms proto-oncogene
09/29/1993EP0380623B1 Irreversible peptide ligands for bombesin receptors
09/29/1993EP0247091B1 Modular assembly of antibody genes, antibodies prepared thereby and use
09/29/1993EP0185034B1 Inhibin isolated from ovarian follicular fluid
09/29/1993CN1076690A Sulfonamidocarboxamides
09/29/1993CN1076629A A 90k tumor-associated antigen, ir-95
09/28/1993US5248770 Molecular probes for adenosine receptors
09/28/1993US5248767 Process for the preparation of a pasteurized immunoglobulin preparation using ethanol
09/28/1993US5248766 Oxirane-modified hemoglobin based composition
09/28/1993US5248688 Mixtures of amino acids
09/28/1993US5248670 Phosphorothioate internucleotide bonds
09/28/1993US5248667 Method of treating psoriasis using synthetic peptide compositions
09/28/1993US5248666 Methods for inhibiting neoplastic cell proliferation using platelet factor 4
09/28/1993US5248606 Dna encoding inactive precursor and active forms of maize ribosome inactivating protein
09/28/1993US5248604 Enzymatically active recombinant human acetylcholinesterase and hosts and vectors for expression thereof
1 ... 2921 2922 2923 2924 2925 2926 2927 2928 2929 2930 2931 2932 2933 2934 2935 2936 2937 2938 2939 2940 2941 ... 3163